(3-Morpholin-4-yl-propyl)-(2-p-tolyl-quinolin-4-yl)-amine

ID: ALA279496

Chembl Id: CHEMBL279496

PubChem CID: 11068428

Max Phase: Preclinical

Molecular Formula: C23H27N3O

Molecular Weight: 361.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2cc(NCCCN3CCOCC3)c3ccccc3n2)cc1

Standard InChI:  InChI=1S/C23H27N3O/c1-18-7-9-19(10-8-18)22-17-23(20-5-2-3-6-21(20)25-22)24-11-4-12-26-13-15-27-16-14-26/h2-3,5-10,17H,4,11-16H2,1H3,(H,24,25)

Standard InChI Key:  KMEPZHHDOXXVGN-UHFFFAOYSA-N

Associated Targets(Human)

NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

WEHI (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.49Molecular Weight (Monoisotopic): 361.2154AlogP: 4.34#Rotatable Bonds: 6
Polar Surface Area: 37.39Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.78CX LogP: 4.01CX LogD: 3.35
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -1.51

References

1. Strekowski L, Say M, Henary M, Ruiz P, Manzel L, Macfarlane DE, Bojarski AJ..  (2003)  Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.,  46  (7): [PMID:12646034] [10.1021/jm020374y]
2. Paliakov E, Henary M, Say M, Patterson SE, Parker A, Manzel L, Macfarlane DE, Bojarski AJ, Strekowski L..  (2007)  Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides.,  15  (1): [PMID:17049254] [10.1016/j.bmc.2006.09.059]
3. An ZY, Yan YY, Peng D, Ou TM, Tan JH, Huang SL, An LK, Gu LQ, Huang ZS..  (2010)  Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.,  45  (9): [PMID:20554355] [10.1016/j.ejmech.2010.05.043]

Source